A Systematic Review of Fetal Genes as Biomarkers of Cardiac Hypertrophy in Rodent Models of Diabetes

Pathological cardiac hypertrophy activates a suite of genes called the fetal gene program (FGP). Pathological hypertrophy occurs in diabetic cardiomyopathy (DCM); therefore, the FGP is widely used as a biomarker of DCM in animal studies. However, it is unknown whether the FGP is a consistent marker...

Descripción completa

Detalles Bibliográficos
Autores principales: Cox, Emily J., Marsh, Susan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963983/
https://www.ncbi.nlm.nih.gov/pubmed/24663494
http://dx.doi.org/10.1371/journal.pone.0092903

Ejemplares similares

Ejemplares similares